RxDoctor Payments Data

Lewis Meyerson, MD

Family Medicine · Columbia, MONPI 1568560720

Payments from drug & device makers

$31in general payments, 2019–2025

Across 2 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$16
  • Johnson & Johnson$15

What the payments were for

  • Food & beverage$31100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$31 in reported general payments places this provider in the 10th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$345,638
Medicare patients
541
Services billed
4,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban2,042$596,181
JardianceEmpagliflozin1,076$330,173
Invega SustennaPaliperidone Palmitate101$305,836
OzempicSemaglutide213$223,672
MyrbetriqMirabegron854$215,179
JanuviaSitagliptin Phosphate599$181,619
Humira(Cf) PenAdalimumab21$151,885
FarxigaDapagliflozin Propanediol317$112,859
AustedoDeutetrabenazine53$108,593
LinzessLinaclotide172$98,468
IngrezzaValbenazine Tosylate15$89,157
XareltoRivaroxaban324$88,329
TrulicityDulaglutide86$87,208
Trelegy ElliptaFluticasone/Umeclidin/Vilanter124$84,160
NuplazidPimavanserin Tartrate26$63,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Xarelto$15$394,165425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →